Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03891563
Other study ID # PREVIEW
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 18, 2017
Est. completion date July 31, 2025

Study information

Verified date July 2023
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Femoroacetabular impingement (FAI) is a condition of the hip where there is a mis-fit between the femoral head (ball) and hip acetabulum (socket). The abnormalities on the hip bones collide or "impinge" during movements such as hip flexion and rotation. Typically, patients with this condition are young adults who present with hip pain, loss of hip function, and in many cases, osteoarthritis later in life. The rate of diagnoses of FAI has dramatically risen across all age groups, but it has been especially notable within adolescent populations. There has been a corresponding increase in the number of surgeries performed on younger and younger hips to treat pain and loss of function due to this condition. Preliminary small-scale research has hypothesized that increased activity, such as sport specialization (i.e. playing only one sport for most of the year) at an early age when the hip is still developing, may be the cause. In the past 20 years, sport injuries among children have dramatically increased, where close to 45 million young athletes participate in organized sports annually in Canada and the US alone. There is a current trend among coaches and parents to have children focus on one sport with the thought that this dedication will allow them to reach an elite level. We are proposing the first international, longitudinal cohort study to determine the effect of sport specialization on the development of FAI during the critical phase of hip development (i.e. between the ages of 12-14 years). Volunteer participants will be recruited across Canada and internationally and will be evaluated clinically and radiographically (i.e. using MRI) over 2 years. This study will not only prospectively evaluate the role of sport activity the development of FAI, but also inform preventative training protocols to potentially reduce its incidence among adolescents, and later as adults, as well as identify parameters to detect hips that are at risk for developing FAI.


Description:

This is a multi-centre, international longitudinal cohort study evaluating 200 participants between the ages of 12-14 that include sport specialists at the moderate to vigorous physical activity (MVPA) level and non-sport specialists at any activity level. Participant groups will be defined according to the AOSSM and AMSSM early sport specialization criteria (2016). We will monitor physical activity levels of all participants using an activity log and a wrist-mounted activity tracker, with synced data collected every 3 months during the study period. In addition, participants will be evaluated clinically and radiographically at time of enrollment and 6, 12, 18, and 24 months. The primary study outcome is the incidence of FAI between groups at 2 years, determined via MRI. Secondary outcomes include hip function and health-related quality of life between subjects diagnosed with FAI versus no FAI at 2 years, as determined by the HOS and PedsQL questionnaires.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 201
Est. completion date July 31, 2025
Est. primary completion date July 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 14 Years
Eligibility Inclusion Criteria: 1. asymptomatic males and females between the ages of 12-14 years 2. ability to speak, understand, and read the language of the clinical site 3. provision of informed child assent (if applicable) and parental consent. Exclusion Criteria: 1. hip is mature (i.e. closed physes) based on the baseline MRI scan 2. hip complaints or pain in the hip 3. previous trauma to the hip 4. previous surgery on the hip 5. significant medical co-morbidities (requiring daily assistance for ADLs) 6. history of or ongoing paediatric hip disease (Legg-Calve-Perthes; slipped capital femoral epiphysis, hip dysplasia) 7. participants that have contraindications and/or are unwilling to undergo an MRI (e.g. claustrophobia) 8. participants who will likely have problems, in the judgment of the investigator, with maintaining follow-up 9. any other reasons the investigator feels is relevant for excluding the subject.

Study Design


Locations

Country Name City State
Canada McMaster University Hamilton Ontario
Canada Chu du Quebec Québec Quebec
Korea, Republic of Kyungpook National University Hospital Daegu North Gyeongsang
Netherlands Erasmus Medical Centre Rotterdam

Sponsors (5)

Lead Sponsor Collaborator
McMaster University Arthroscopy Association of North America, Canadian Institutes of Health Research (CIHR), Conmed, McMaster Surgical Association

Countries where clinical trial is conducted

Canada,  Korea, Republic of,  Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of radiographic FAI The primary outcome is the incidence of radiographic FAI between groups at 2 years, as determined by the dedicated MRI of the hip. We will identify both symptomatic and asymptomatic cases, where asymptomatic FAI can become symptomatic in young adulthood, and/or could be associated with idiopathic osteoarthritis later in life. 2 years
Secondary Hip function As determined by the Hip Outcome Score 2 years
Secondary Health-related quality of life As determined by the Pediatric Quality of Life questionnaire 2 years
See also
  Status Clinical Trial Phase
Completed NCT01623843 - Femoroacetabular Impingement RandomiSed Controlled Trial N/A
Completed NCT03669471 - Muscular and Functional Performance in FAIS Patients
Not yet recruiting NCT05031390 - the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study N/A
Active, not recruiting NCT05025956 - Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan Phase 1/Phase 2
Withdrawn NCT02674113 - Regional Anesthesia in Hip Arthroscopy N/A
Withdrawn NCT02260726 - Evaluation of Ultrasound for Detecting Hip Impingement N/A
Recruiting NCT05391204 - Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls N/A
Active, not recruiting NCT04069507 - Healthy Hip Study: Conservative Management for Pre-arthritic Hip Disorders
Terminated NCT03278353 - Fulfillment of Expectations for Patients With FAI Syndrome N/A
Terminated NCT03995290 - 3D Modeling to Improve Hip Arthroscopy Outcomes
Completed NCT06082271 - Comparative, Randomized Study on the Anti-inflammatory and Regenerative Efficacy of a New Medical Device (DM) Based on Hydrolyzed Collagen Peptides in Patients With Femoro-acetabular Impingement Undergoing Hip Arthroscopy N/A
Recruiting NCT01621360 - Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement N/A
Completed NCT04980209 - The Feasibility and Application of Intraoperative Ultrasound to Evaluate Femoral Head Shaping
Enrolling by invitation NCT04988659 - Analysis of Gene Expression in Femoroacetabular Impingement (FAI)
Active, not recruiting NCT03494660 - SCP Hip Outcomes Study
Active, not recruiting NCT04822571 - Investigating the Reliability of Highly Dynamic 3D Motion Analysis Protocol in Adolescence and Adult Males N/A
Withdrawn NCT02706756 - Conservative Intervention of Femoroacetabular Impingement Syndrome N/A
Completed NCT01993615 - A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial N/A
Completed NCT01814124 - Conservative Management of Femoroacetabular Impingement N/A
Completed NCT02702661 - PRCT of FICB vs LAI for Hip Arthroscopy N/A